At the vanguard of metabo-oncology
Drug candidate SDX-7320, which has already undergone Phase 1 study, offsets hyperglycemia caused by PI3K/Akt/mTOR cancer therapies and restores insulin sensitivity, according to recent preclinical research
Preclinical Research
Defeating Venezuelan equine virus with a decoy
A decoy molecule could help to contain outbreaks of Venezuelan equine encephalitis infection
Science on fast-forward
Many don’t realize how little “settled science” we’ve got, and the last nine months have brought science out front on a new scale
Spotlight on Cell Biology: Cell biology takes the stage
ASCB|EMBO annual meeting goes virtual this year with cellular research
An antisense-ible arrangement
Evotec and Secarna partner on antisense-based therapeutics
Building a database around RNA and proteins
eCLIP technology helps uncover how RNA binding proteins regulate gene expression
Hope for frontotemporal dementia patients
Passage Bio plans Phase 1/2 trial of gene therapy in humans based on preclinical results
BioNTech and Pfizer report BNT162b2 data
BNT162b2 immunization of rhesus macaques results in strong antiviral effects against SARS-CoV-2
Preclinical pancreatic cancer partnership
Relationship targets use of pipeline drug and AI platform
New means for managing myotonic dystrophy
RNA-targeting gene therapy reverses molecular and functional features of DM1 in mice
Europital expands into a full-service CRO
New capabilities include project management, clinical monitoring and pharmacovigilance
